Chronic β-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress

Journal of Pharmacology and Experimental Therapeutics

Volumn 318, Issue 2, 2006, Pages 469-475

  Hu, Aihua ^a   Jiao, Xiangying ^a   Gao, Erhe ^a   Koch, Walter J ^a   Sharifi Azad, Said ^a   Grunwald, Zvi ^a   Ma, Xin L ^a   Sun, Jian Zhong ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; [N (3 AMINOMETHYL)BENZYL)ACETAMIDINE]; ISOPRENALINE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PEROXYNITRITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BETA ADRENERGIC STIMULATION; CIRCULATION; CONTROLLED STUDY; HEART INJURY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; IMMUNOCHEMISTRY; MOUSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; STRESS; UPREGULATION;

ADRENERGIC BETA-AGONISTS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; C-REACTIVE PROTEIN; HEART; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; ISOPROTERENOL; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RNA; STRESS; TYROSINE;

EID: 33745962819     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.102160     Document Type: Article

References (37)

1. Arstall MA, Sawyer DB, Fukazawa R, and Kelly RA (1999) Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric-oxide synthase induction and peroxynitrite generation. Circ Res 85:829-840.
2. Ballou SP and Lozanski G (1992) Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 4:361-368.
3. Bernard AC, Fitzpatrick EA, Maley ME, Gellin GL, Tsuei BJ, Arden WA, Boulanger BR, Kearney PA, and Ochoa JB (2000) Beta adrenoceptor regulation of macrophage arginase activity. Surgery 127:412-418.
4. Bharadwaj D, Stein MP, Volzer M, Mold C, and Du Clos TW (1999) The major receptor for C-reactive protein on leukocytes is fcγreceptor II. J Exp Med 190:585-590.
5. Bristow MR (2000) β-Adrenergic receptor blockade in chronic heart failure. Circulation 101:558-569.
6. Chi DS, Qui M, Krishnaswamy G, Li C, and Stone W (2003) Regulation of nitric oxide production from macrophages by lipopolysaccharide and catecholamines. Nitric Oxide 8:127-132.
7. Colucci WS, Sawyer DB, Singh K, and Communal C (2000) Adrenergic overload and apoptosis in heart failure: implications for therapy. J Card Fail 6:1-7.
8. Egi K, Conrad NE, Bedynek A, Ferdinandy P, Reichart B, and Wildhirt SM (2001) Improvement of cardiac allograft function by 1400W, a highly selective inducible nitric oxide synthase inhibitor and superoxide dismutase - role of peroxynitrite. J Heart Lung Transplant 20:154.
9. Ferdinandy P and Schulz R (2003) Nitric oxide, superoxide and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 138:532-543.
10. Funakoshi H, Kubota T, Kawamura N, Machida Y, Feldman AM, Tsutsui H, Shimokawa H, and Takashita A (2002) Disruption of inducible nitric oxide synthase improves beta-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy. Circ Res 90:959-965.
11. Gao F, Christopher TA, Lopez BL, Friedman E, Cai G, and Ma XL (2000) Mechanism of decreased adenosine protection in reperfusion injury of aging rats. Am J Physiol 279:H329-H338.
12. Gao F, Gong B, Christopher TA, Lopez BL, Karasawa A, and Ma XL (2001) Anti-apoptotic effect of benidipine, a long-lasting vasodilating calcium antagonist, in ischaemic/reperfused myocardial cells. Br J Pharmacol 132:869-878.
13. Gao F, Yue TL, Shi DW, Christopher TA, Lopez BL, Ohlstein EH, Barone FC, and Ma XL (2002) p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation. Cardiovasc Res 53:414-422.
14. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, and Knowles RG (1997) 1400W is a slow, tight binding and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 272:4959-4963.
15. Gealekman O, Abassi Z, Rubinstein I, Winaver J, and Binah O (2002) Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overloaded heart failure. Circulation 105:236-243.
16. Gustafsson AB and Brunton LL (2000) beta-Adrenergic stimulation of rat cardiac fibroblasts enhances induction of nitric-oxide synthase by interleukin-1beta via message stabilization. Mol Pharmacol 58:1470-1478.
17. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, et al. (1996) Expression of inducible nitric oxide synthase in human heart failure. Circulation 93:1087-1094.
18. Ikeda U, Maeda Y, Yamamoto K, and Shimada K (2002) C-reactive protein augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. Cardiovasc Res 56:86-92.
19. Kelly RA, Balligand JL, and Smith TW (1996) Nitric oxide and cardiac function. Circ Res 79:363-380.
20. Kim YM, Bombeck CA, and Billiar TR (1999) Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 84:253-256.
21. Kurosaki K, Ikeda U, Maeda Y, and Shimada K (2000) Carvedilol stimulates nitric oxide synthesis in rat cardiac myocytes. J Mol Cell Cardiol 32:333-339.
22. Lefkowitz RJ, Rockman HA, and Koch WJ (2000) Catecholamines, cardiac beta-adrenergic receptors and heart failure. Circulation 101:1634-1637.
23. Li D, Qu Y, Tao L, Liu H, Hu A, Gao F, Sharifi-Azad S, Grunwald Z, Ma XL, and Sun JZ (2006) Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury. J Surg Res 131:64-72.
24. Lin WC, Tsai PS, and Huang CJ (2005) Catecholamines' enhancement of inducible nitric oxide synthase-induced nitric oxide biosynthesis involves CAT-1 and CAT-2A. Anesth Analg 101:226-232.
25. Ma XL, Gao F, Nelson AH, Lopez BL, Christopher TA, Yue TL, and Barone FC (2001) Oxidative inactivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats. J Pharmacol Exp Ther 298:879-885.
26. Mungrue IN, Gros R, You X, Pirani A, Azad A, Csont T, Schulz R, Butany J, Stewart DJ, and Husain M (2002) Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block and sudden death. J Clin Investig 109:735-743.
27. Nathan C (1997) Inducible nitric oxide synthase: what difference does it make? J Clin Investig 100:2417-2423.
28. Razavi HM, Hamilton JA, and Feng Q (2005) Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol Ther 106:147-162.
29. Remondino A, Kwon SH, Communal C, Pimentel DR, Sawyer DB, Singh K, and Colucci WS (2003) β-Adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res 92:136-138.
30. Singh K, Xiao L, Remondino A, Sawyer DB, and Colucci WS (2001) Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol 189:257-265.
31. Song W, Lu X, and Feng Q (2000) Tumor necrosis factor-alpha induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes. Cardiovasc Res 45:595-602.
32. Tao L, Gao E, Bryan NS, Qu Y, Liu HR, Hu A, Christopher TA, Lopez BL, Yodoi J, Koch WJ, et al. (2004) Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation [corrected]. Proc Natl Acad Sci USA 101:11471-11476.
33. Tian B, Liu J, Bitterman PB, and Bache RJ (2002) Mechanisms of cytokine induced NO-mediated cardiac fibroblast apoptosis. Am J Physiol 283:H1958-H1967.
34. Vinten-Johansen J (2000) Physiological effects of peroxynitrite. Potential products of the environment. Circ Res 87:170-172.
35. Walker LM, Walker PD, Imam SZ, Ali SF, and Mayeux PR (2000) Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric-oxide synthase inhibitor L-N6-(1-iminoethyl)lysine. J Pharmacol Exp Ther 295:417-422.
36. Yeh ET (2004) CRP as a mediator of disease. Circulation 109 (Suppl 2):II-11-II-14.
37. Zhang L, Looney CG, Qi WN, Chen LE, Seaber AV, Stamler JS, and Urbaniak JR (2003) Reperfusion injury is reduced in skeletal muscle by inhibition of inducible nitric oxide synthase. J Appl Physiol 94:1473-1478.